Validations: Viral Clearance Strategy & Spiking Studies

Interpretation Packages: Tables, Graphs, and Narratives

Interpretation Packages: Tables, Graphs, and Narratives in Viral Clearance Validation In the evolving landscape of biopharmaceuticals, understanding the intricacies of viral clearance validation is essential. This guide aims to provide a comprehensive overview of the processes involved in establishing effective viral clearance through spiking studies, particularly in the context of closed and single-use systems. It is tailored for professionals in…

Continue Reading Interpretation Packages: Tables, Graphs, and Narratives

Viral Surrogates & Model Selection: Defensibility in Filings

Viral Surrogates & Model Selection: Defensibility in Filings Viral Surrogates & Model Selection: Defensibility in Filings In the realm of biopharmaceutical development, particularly when dealing with advanced therapy medicinal products (ATMPs) and biologics, ensuring viral safety is of paramount importance. The regulatory guidelines from authorities such as the US FDA, EU EMA, and UK MHRA emphasize the necessity of rigorous…

Continue Reading Viral Surrogates & Model Selection: Defensibility in Filings

Inactivation vs Removal: Combining for Robust LRVs

Inactivation vs Removal: Combining for Robust LRVs This guide aims to provide a comprehensive understanding of inactivation and removal strategies for viral clearance validation, especially in the context of advanced therapy medicinal products (ATMPs). Both inactivation and removal are essential components of a robust viral clearance strategy, and their effective combination can significantly enhance the robustness of large reductions in…

Continue Reading Inactivation vs Removal: Combining for Robust LRVs

Assay Readouts: TCID50, qPCR, and Plaque—What to Use

Assay Readouts: TCID50, qPCR, and Plaque—What to Use Assay Readouts: TCID50, qPCR, and Plaque—What to Use This comprehensive guide will provide a step-by-step analysis of the assay readouts TCID50, qPCR, and Plaque assays, emphasizing their respective roles in viral clearance validation in the context of spiking studies. The focus will also include the considerations necessary for closed systems and single-use…

Continue Reading Assay Readouts: TCID50, qPCR, and Plaque—What to Use

Controls & Blanks in Spiking Studies: Catching False Positives

Controls & Blanks in Spiking Studies: Catching False Positives Controls & Blanks in Spiking Studies: Catching False Positives In the realm of biopharmaceuticals, ensuring the safety and efficacy of therapeutics is paramount. Viral clearance validation (VCV) stands as a critical aspect, particularly in spiking studies employed within closed systems and single-use systems. This article serves as a comprehensive step-by-step tutorial…

Continue Reading Controls & Blanks in Spiking Studies: Catching False Positives

Clearance Variability: Replicates, Confidence, and Safety Margins

Clearance Variability: Replicates, Confidence, and Safety Margins Understanding Viral Clearance Validation Viral clearance validation is an essential component in the development and manufacturing of biologics and advanced therapy medicinal products (ATMPs). As per ICH Q5A(R2) guidelines, demonstrating the effectiveness of viral clearance processes ensures that medicinal products are safe for human use. The regulatory landscape, particularly within FDA, EMA, and…

Continue Reading Clearance Variability: Replicates, Confidence, and Safety Margins

Nanofiltration: PVDF/PES Selection and Integrity Testing

Nanofiltration: PVDF/PES Selection and Integrity Testing Nanofiltration: PVDF/PES Selection and Integrity Testing In the realm of pharmaceutical validation, particularly concerning biologics and advanced therapy medicinal products (ATMPs), nanofiltration plays a crucial role in ensuring viral safety. This article is designed as a step-by-step tutorial guide to assist pharmaceutical professionals in mastering the selection and integrity testing of polyvinylidene fluoride (PVDF)…

Continue Reading Nanofiltration: PVDF/PES Selection and Integrity Testing

Nanofiltration: PVDF/PES Selection and Integrity Testing

Nanofiltration: PVDF/PES Selection and Integrity Testing Nanofiltration: PVDF/PES Selection and Integrity Testing Nanofiltration plays a critical role in viral clearance validation, particularly for biologics and advanced therapy medicinal products (ATMP). This tutorial guide provides a structured approach for the selection of PVDF (polyvinylidene fluoride) and PES (polyethersulfone) membranes, as well as integrity testing methods essential for maintaining aseptic conditions in…

Continue Reading Nanofiltration: PVDF/PES Selection and Integrity Testing

Heat/UV/Other Treatments: Applicability and Limits

Heat/UV/Other Treatments: Applicability and Limits Heat/UV/Other Treatments: Applicability and Limits Introduction to Viral Clearance Validation In the context of pharmaceutical manufacturing, particularly for biologics and advanced therapy medicinal products (ATMPs), viral clearance validation is essential for ensuring the safety and efficacy of the final product. By understanding the viral clearance processes and their limitations, professionals can navigate the complex regulatory…

Continue Reading Heat/UV/Other Treatments: Applicability and Limits

Heat/UV/Other Treatments: Applicability and Limits

Heat/UV/Other Treatments: Applicability and Limits Heat/UV/Other Treatments: Applicability and Limits 1. Introduction to Viral Clearance Validation Viral clearance validation is a critical component in the development and manufacture of biologics, advanced therapy medicinal products (ATMPs), and other pharmaceuticals that can potentially carry viral contaminants. Various treatments, including heat, ultraviolet (UV) light, and other physical or chemical methods, are employed to…

Continue Reading Heat/UV/Other Treatments: Applicability and Limits